Snoring can be a terribly frustrating problem for the snorer and those impacted by the nightly disruption of loud snoring. We are extremely proud of the profound impact Theravent LITE, REGULAR and MAX are having on thousands of snorers each night.
SAN JOSE, CA (PRWEB) February 11, 2015
Theravent, Inc., a medical device company that provides easy-to-use, non-invasive solutions to help people stop snoring, recently hit a huge milestone by exceeding 2 million nights in snoring-treatment sales. To celebrate, Theravent launched an exciting new Trial Pack, which features all three strengths of the device: LITE, REGULAR and MAX. Each device uses Expiratory Positive Airway Pressure (EPAP) therapy to harness the power of your own breath and help treat snoring in a personalized manner - LITE features half the EPAP resistance of REGULAR to help quieter snorers, while MAX offers twice the resistance for louder, heavier snoring sufferers.
Clinically proven by leading sleep specialists to treat snoring, EPAP therapy represents a breakthrough in the battle against snoring. It features MicroValve technology, which attaches to and covers the nostrils to create pressure during exhalation. EPAP keeps pressure in a person's airway while they sleep to significantly reduce or eliminate snoring.
"Snoring can be a terribly frustrating problem for the snorer and those impacted by the nightly disruption of loud snoring. We are extremely proud of the profound impact Theravent LITE, REGULAR and MAX are having on thousands of snorers each night," said Theravent, Inc. CEO Matt Williams. "The benefits of treating snoring also go beyond a quieter night and extend to something vital to us all: A good night sleep!"
Thousands of sleep physicians have recommended Theravent and the prescription version of EPAP treatment, Provent, to treat patients with all ranges of sleep disordered breathing. To learn more,
visit http://www.theraventsnoring.com or call 1-888-SLP-WELL (1-888-757-9355).
Theravent, Inc. is a privately-held medical device company dedicated to providing non-invasive medical solutions for people with sleep disordered breathing. Based on its innovative MicroValve technology and patented designs, Theravent, Inc. has developed a unique line of clinically-proven medical devices to address the continuum of sleep disorders from severe obstructive sleep apnea (OSA) to mild snoring. Theravent, Inc.'s devices work by creating expiratory positive airway pressure (EPAP). The company markets prescription-only Provent Sleep Apnea Therapy, a discreet, easy-to-use nasal device for the treatment of OSA, and Theravent Snore Therapy, an over-the-counter device for the treatment of primary snoring, in the US. Provent is also available in Australia, New Zealand, Canada, Hong Kong, Singapore and South Africa. For more information, please visit http://www.proventtherapy.com or http://www.theravent.com.